Overexpression of CDC25A and CDC25B in head and neck cancers

Cancer Research

Volumn 57, Issue 12, 1997, Pages 2366-2368

  Gasparotto, Daniela ^a   Maestro, Roberta ^a   Piccinin, Sara ^a   Vukosavljevic, Tamara ^a   Barzan, Luigi ^b   Sulfaro, Sandro ^b   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Pordenone Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MYC PROTEIN; PHOSPHATASE;

ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; ONCOGENE H RAS; ONCOGENE MYC; PHOSPHORYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; PHOSPHOPROTEIN PHOSPHATASE; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0030972853     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
2. IARC Working Group on the Evaluation of Carcinogen Risk to Humans. IARC Monographs on the Evaluation of Carcinogen Risks to Humans, Tobacco Smoking, Vol. 38. Lyon, France: IARC, 1986.
3. IARC Working Group on the Evaluation of Carcinogen Risk to Humans. IARC Monographs on the Evaluation of Carcinogen Risks to Humans, Alcohol Drinking, Vol. 44. Lyon, France: IARC, 1988.
4. Pines, J. Cyclins and cyclin-dependent kinases: theme and variations. Adv. Cancer Res., 66: 181-212, 1995.
5. Galaktionov, K., and Beach, D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell. 67: 1181-1194, 1991.
6. Nagata, A., Igarashi, M., Jinno, S., Suto, K., and Okayama, H. An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol., 3: 959-968, 1991.
7. 2. Proc. Natl. Acad. Sci. USA, 87: 5139-5143, 1990.
8. Kakizuka, A., Sebastian, B., Borgmeyer, V., Hermans-Borgmeyer, I., Bolado, J., Hunter, T., Hoekstra, M. F., and Evans, R. M. A mouse cdc25 homolog is differentially and developmentally expressed. Genes & Dev., 6: 578-590, 1992.
9. Hoffmann, I., Clarke, P. R., Marcote, M. J., Karsenti, E., and Draetta, G. Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J., 12: 53-63, 1993.
10. Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach, D. cdc25 phosphatases as potential human oncogenes. Science (Washington DC). 269: 1575-1577, 1995.
11. Galaktionov, K., Chen, X., and Beach, D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond.), 328: 511-517, 1996.
12. Spitkovsky, D., Jansen-Durr, P., Karsenti, E., and Hoffmann, I. S-phase induction by adenovirus E1A requires activation of cdc25A tyrosine phosphatase. Oncogene, 12: 2549-2554, 1996.
13. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
14. Gilliland, G., Perrin, S., Blanchard, K., and Bunn, H. F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 2725-2729, 1990.
15. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (Amst.), 77: 51-59, 1989.
16. Rhoads, D. D., Dixit, A., and Roufa, D. J. Primary structure of human ribosomal protein S14 and the gene that encodes it. Mol. Cell. Biol., 6: 2774-2783, 1986.
17. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
18. Maestro, R., Dolcetti, R., Gasparotto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E., and Boiocchi, M. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene, 7: 1159-1166, 1992.
19. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
20. 1-S transition. EMBO J., 13: 4102-4310, 1994.
21. Galaktionov, K., Jessus, C., and Beach, D. Raf1 interaction with cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes & Dev., 9: 1046-1058, 1995.
22. Conklin, D. S., Galaktionov, K., and Beach, D. 14-3-3 proteins associate with CDC25 phosphatases. Proc. Natl. Acad. Sci. USA, 92: 7892-7896, 1995.
23. Field, J. K. Oncogenes and tumor suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol. Eur. J. Cancer, 28B: 67-76, 1992.
24. Horiguchi, T., Nishi, K., Hakoda, S., Tanida, S., Nagata, A., and Okayama, H. Dnacin 1 and Dnacin B1 are antitumor antibiotics that inhibit cdc25B phosphatase activity. Biochem. Pharmacol., 48: 2139-2141, 1994.